Related Experiment Videos
[Erectile dysfunction].
1Urologischen Abteilung, Krankenhaus der Barmherzigen Brüder Wien, Grosse Mohrengasse 9, A-1020 Wien. abteilung.urologie@bbwien.at
Wiener Medizinische Wochenschrift (1946)
|January 31, 2002
Summary
Erectile dysfunction affects nearly 10% of men, with risk factors including age and chronic illnesses. Modern diagnostics and treatments, like Sildenafil, offer effective solutions, often combined with psychotherapy for optimal outcomes.
Area of Science:
- Urology
- Andrology
Context:
- Erectile dysfunction (ED) is a significant urological concern, affecting nearly 10% of men.
- Risk factors for ED include advanced age, diabetes, hypertension, smoking, and pelvic surgeries.
- The Androcheck annual medical examination for men over 50 addresses ED prevalence.
Purpose:
- To outline modern, multi-step diagnostic approaches for erectile dysfunction.
- To evaluate the impact of oral phosphodiesterase-5 inhibitors, such as Sildenafil, on ED treatment paradigms.
- To emphasize the importance of personalized therapy and combination approaches for ED management.
Summary:
- Current ED diagnostics integrate patient and partner therapeutic requests from the outset.
- Sildenafil has revolutionized ED therapy, reducing the need for more invasive treatments like intraurethral prostaglandins or auto-injections.
- Despite advancements, combining various therapeutic options and incorporating psychotherapy/couple therapy is crucial for comprehensive ED management.
Impact:
- The advent of oral medications like Sildenafil has shifted the landscape of ED treatment options.
- A personalized, step-wise diagnostic and therapeutic strategy ensures optimal outcomes for patients with erectile dysfunction.
- Integrating psychological support alongside medical interventions enhances the overall success rate in treating ED.